Home  »  Ipo Review  »  Inventia Healthcare Limited Ipo

Inventia Healthcare Limited  are a pharmaceutical development and manufacturing company headquartered in Mumbai with over 30 years of operations. Their focus is on development of value added oral solid dosage formulations (“OSDF”). Over the years, they have developed capabilities in offering end to end solutions in the product development process, right from research and development all the way to final manufacturing and packaging . Inventia Healthcare Limited IPO comprises of  [●]  Equity shares, face value of Rs.10 each.

Let’s have a detailed review of the company and analytics of the Inventia Healthcare Limited IPO release date, IPO offer price, subscription, Inventia Healthcare Limited IPO allotment, grey market price and other details like the company’s background, its financial positions, its promoters and other related things.Stock Broker Complaints


Inventia Healthcare Limited IPO Review & Ratings

IPO Ratings & Review
CriteriaRatings
Industry Sentiments8.5/10
Industry Ranking7.8/10
Company Background7.9/10
Company Reputation7.9/10
Competitive Edge7.7/10
Financial Statements7.8/10
Popularity Index8.4/10
Promoters Reputation7.7/10
Retail Appetite7.9/10
Top Brokers Review7.9/10
Overall Ratings8.1/10
Star Ratings★★★★☆

Summary of Inventia Healthcare Limited   IPO

Inventia Healthcare Limited IPOInventia Healthcare Limited  are a pharmaceutical development and manufacturing company headquartered in Mumbai with over 30 years of operations. Their focus is on development of value added oral solid dosage formulations (“OSDF”). Over the years, they have developed capabilities in offering end to end solutions in the product development process, right from research and development all the way to final manufacturing and packaging.The Issue comprises of a Public Issue of [●]  Equity shares of face value of Rs.10.00 each fully paid  up.

From FY 2014-15 to FY 2016-2017, as per the Restated Financial Statements,

From fiscal 2016 to 2017, company’s revenue from operations and net profit has increased at a growth rate of  13.43% and 53.50%, respectively.

For the period ended March 31, 2018, FY 2016-17 and FY 2015-16, its revenue from operations was Rs. 3,108.21 Millions, Rs. 2,804.19 Millions and Rs. 2,472.28 Millions, respectively representing growth of  13.43% from the FY 2015-16 to FY 2016-17. For the period ended March 31, 2018, FY 2016-17 and FY 2015-16 our net profit was Rs. 261.24 Millions, Rs. 241.40 Millions and Rs. 164.54 Millions, respectively, representing a growth of  53.50 % from the FY 2015-16 to FY 2016-17.

  • During the financial year 2017-18 the Other Income of our company decreased to Rs. 15.79 Millions as against Rs.  30.48 Millions for the financial year 2016-17 .
  • Company’s Net Profit after tax for the year 2016-17 is Rs.157.08  Millions from the year 2015-16 of Rs. 141.84 Millions showing an increase of 11.34% from last year, showing remarkable performance.

The Promoter of this company is Janak Shah, Maya Shah, Ankur Shah Trust and Vishal Shah Trust. The lead manager to the issue is  ICICI Securities Limited and Centrum Capital Limited and the Registrar to this issue is Link Intime India Private Limited .


Open Free* Demat A/C Now! Fill the details below

    Fill Your Details Here



    Inventia Healthcare Limited IPO Date

    The opening and the closing date of Inventia Healthcare Limited  IPO is not known yet.


    Inventia Healthcare Limited IPO Subscription

    Day / DateQIBNIIRIITotal Subscription
    Day 1 
    Day 2
    Day 3
    Day 4
    Day 5
    Shares Offered or Net Issue

    The shares subscribed by the public will be updated herein on a daily basis, once the IPO is open for subscription.


    Inventia Healthcare Limited IPO Allotment Status

    Here, you can find the Allotment Status of this IPO.


    Inventia Healthcare Limited IPO Price Band

    The face value of each share is Rs 10, but the price band of the IPO is not yet disclosed. 


    Inventia Healthcare Limited IPO Equity Share Offering

    [●] Equity Shares of Rs 10/- each but Issue Price is yet to be disclosed .


    Inventia Healthcare Limited – Company Overview

    Inventia Healthcare Limited  are a pharmaceutical development and manufacturing company headquartered in Mumbai with over 30 years of operations. Their focus is on development of value added oral solid dosage formulations (“OSDF”). Over the years, they have developed capabilities in offering end to end solutions in the product development process, right from research and development all the way to final manufacturing and packaging .They develop and manufacture their products in-house. Once a product is developed, the Company partner with mid-sized and large pharmaceutical companies and distributors which have a local or multi-national presence to sell our products across various jurisdictions.

    Unlike contract research and contract manufacturing companies, for most of their products, the proprietary technology and manufacturing rights remain with their Company and these products are sold on a non-exclusive basis under the partner’s brand name.

    The Company is promoted by  Janak Shah, Maya Shah, Ankur Shah Trust and Vishal Shah Trust and is the guiding force behind the growth and strategic decisions of the Company.

    Competitive Strengths of Inventia Healthcare Limited :

    • Accredited research and manufacturing facilities which enables us to provide end to end solutions as well as serve multiple jurisdictions
    • Multifaceted product selection process targeting value added OSDF products which have high margins
    • Flexible business model and long-standing relationship with  partners
    • Experienced management team with extensive industry experience and proven track record

    Business strategies of Inventia Healthcare Limited :

    • Continue to focus on value added OSDF with high entry barriers which can be marketed in multiple regions
    • Foray into high growth injectables segment
    • Foray into the nutraceuticals segment
    • Expand  research and development and manufacturing capabilities
    • Selling  finished formulations under their brand and bid for government and institutional tenders in the domestic market

    Inventia Healthcare Limited – Financial Statements

    A quick look into the past financial performance of the company to understand its performance of business and evaluate the growth prospectus:

    Financial Summary:

    Amount (in INR & Millions)
    31-Mar-1831-Mar-1731-Mar-1631-Mar-1531-Mar-14
    Total Assets3,757.052,810.052,710.802,297.402,031.04
    Total Revenue3,108.212,804.192,472.282,090.421,798.28
    Total Expense2,655.562,418.912,155.821,896.541,662.47
    Profit After Tax157.08141.84133.5344.0528.48

    Earnings per Equity Share (in Millions)

    31-Mar-1831-Mar-1731-Mar-16
    Basic & Diluted15.0413.5812.79

    From the above statements, one could find that the Inventia Healthcare Limited may perform well.


    Inventia Healthcare Limited IPO – Promoters

    The Promoter of this company are:

    1. Janak Shah
    2. Maya Shah
    3. Ankur Shah Trust
    4. Vishal Shah Trust

    List of Related Parties (Key Managerial Personnel)

    • Janak Shah
    • Maya Shah
    • Ankur Shah

    Interest in promotion of the Company

    Company is currently promoted by the Promoters in order to carry on its present business. Promoters are interested in the Company to the extent of their shareholding and directorship of the Individual Promoter in the Company and the dividend declared, if any, by the Company. The Promoters are interested in the transactions entered into the Company and the Promoter Group.

    Property Interest

    The promoters along with the promoter group will continue to hold collectively some percentage of the equity share capital of the company. As a result of the same, they will be able to exercise significant influence over the control of the outcome of the matter that requires approval of the majority shareholders vote.

    Interest in Intellectual Rights of the Company

    Promoters has not shown any interest in acquiring the intellectual rights of the company.


    Inventia Healthcare Limited IPO Offer Details or Issue Details

     Particulars No. Of Equity Shares
     Equity Shares Offered Up to [●] Equity Shares, aggregating up to Rs.[●] million
     Of which:
     Reserved for Market Makers Up to [●] Equity Shares, aggregating up to Rs.1,250 million
     Net Issue to the Public Up to 3,164,000 Equity Shares, aggregating up to Rs.[●] million
     Of which:
     Retail Investors Portion Not less than [●] Equity Shares
     Non-Retail Investors PortionNot less than [●] Equity Shares
     Equity Shares outstanding prior to the Issue10,444,000 Equity Shares
     Equity Shares outstanding after the Issue[●] Equity Shares

    Inventia Healthcare Limited IPO Issue Object

    These are the IPO Issue Objects of the company

    •  Pre-payment or repayment of all or a portion of certain outstanding borrowings availed by our Company;
    • General corporate purposes.

     

    Inventia Healthcare Limited IPO – Basis of the Offer Price

    The issue price is determined by the company in consultation with the Lead manager on the basis of the following qualitative and quantitative factors.

    Qualitative factors are:

    • Accredited research and manufacturing facilities approved by various regulatory authorities;
    •  Multifaceted product selection process targeting high margin value added OSDF products;
    • Flexible business model and long-standing relationship with  partners;
    • Experienced management team with extensive industry experience.

    The relevant quantitative factors are:

    Basic & Diluted EPSRONW (%)
    31-Mar-1615.049.01
    31-Mar-1713.588.64
    31-Mar-1812798.61
    • Industry P/E Ratio:
    ParticularsP/E ratio
    Average25.00
    Highest50.53
    Lowest21.81
    • Competitive Peers:
    ParticularsFace Value (in Rs.)EPS     (In Rs.)P/E RatioRONW (%) NAV (In Rs.)
    Caplin Point Laboratories Limited2.0019.1627.3939.7548.21
    Granules India Limited1.0054721.8110.7151.38
    Marksans Pharma Limited1.000.8047.887.4511.74

     

    Inventia Healthcare Limited IPO Lead Managers

    Lead Managers
    ICICI Securities Limited
    Centrum Capital Limited

    Inventia Healthcare Limited IPO Registrar to offer

    Registrar to the Offer
    LINK INTIME INDIA PRIVATE LIMITED
    C-101, 1st Floor, 247 Park, L.B.S. Marg,
    Vikhroli (West), Mumbai – 400 083, India
    Tel: +91 22 49186200; Fax: +91 22 4918 6195
    Website: www.linkintime.co.in
    Email: electra.ipo@linkintime.co.in
    Investor Grievance Id: electra.ipo@linkintime.co.in
    Contact Person: Shanti Gopalkrishnan
    SEBI Registration Number: INR000004058

    Other Details:

    • Statutory Auditor –  S R B C & CO LLP, Chartered Accountants.
    • Peer Review Auditor –    S R B C & CO LLP, Chartered Accountants 
    • Bankers to the Company –  HDFC Bank

    Inventia Healthcare Limited IPO Review by Top 10 Stock Brokers

    Top Stock Brokers ReviewCompany ReputationCompetitive EdgeFinancial StatementPopularity IndexPromoters Reputation
    Angel Broking7.5/107.4/108.5/108.1/107.1/10
    Sharekhan7.2/107.1/108.6/108.1/107.2/10
    Kotak Securities7.3/107.5/108.4/108.1/107.3/10
    ICICI Direct7.3/107.3/108.7/108.1/107.1/10
    IIFL7.5/107.2/108.8/108.0/107.1/10
    Edelweiss7.5/107.4/108.4/108.3/107.2/10
    Zerodha7.4/107.1/108.5/108.1/107.0/10
    5Paisa7.1/107.1/108.4/108.1/107.1/10
    Karvy7.4/107.3/108.2/108.1/107.1/10
    Motilal Oswal7.1/107.1/108.6/108.3/107.2/10

    Inventia Healthcare Limited IPO Grey Market Premium

    The Inventia Healthcare Limited IPO Grey Market Premium price is Rs X, the Kostak rate is Rs X and the Subject to Sauda is X. 


    Open Free* Demat A/C Now! Fill the details below

      Fill Your Details Here


      Inventia Healthcare Limited IPO News

      News 1 – IPO ISSUE OPENS SOON (Download Prospectus)


      Market Guide


      Featured Topics

       

      Get 90% Discount on Brokerage Now! Open Demat Account